Premium
Localization of Cathepsin K and Tartrate‐Resistant Acid Phosphatase in Synovium and Cranial Cruciate Ligament in Dogs with Cruciate Disease
Author(s) -
Muir Peter,
Schamberger Gwenn M.,
Manley Paul A.,
Hao Zhengling
Publication year - 2005
Publication title -
veterinary surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.652
H-Index - 79
eISSN - 1532-950X
pISSN - 0161-3499
DOI - 10.1111/j.1532-950x.2005.00036.x
Subject(s) - cruciate ligament , medicine , cathepsin , acid phosphatase , pathology , cathepsin k , tartrate resistant acid phosphatase , inflammation , anterior cruciate ligament , enzyme , anatomy , chemistry , biochemistry , osteoclast , receptor
Objective— To localize cathepsin K and tartrate‐resistant acid phosphatase (TRAP) in synovium and cranial cruciate ligament (CCL) of dogs with cruciate disease. Animals— Dogs (n=15) with cruciate disease and ruptured CCL, and 12 dogs with intact CCL. Methods— Synovium and CCL were examined histologically and cells containing cathepsin K or TRAP were identified immunohistochemically and histochemically, respectively. Results— Increased cellular localization of cathepsin K and TRAP was detected in synovium and ruptured CCL in dogs with cruciate disease, when compared with tissues from dogs with intact CCL. Inflammation of synovium with TRAP + macrophage‐like cells was seen in 73% of dogs with CCL disease, but was not seen in dogs with intact CCL. The presence of cathepsin K and TRAP protein in synovium and CCL tissues was significantly correlated in dogs with CCL rupture. Conclusion— Inflammation of the epiligament of ruptured CCL with cathepsin K + and TRAP + macrophage‐like cells forms part of a similar, more generalized chronic inflammatory change within the periarticular tissues of the stifle of a large proportion of dogs with CCL rupture. Clinical Relevance— Production of matrix‐degrading enzymes by the synovium may induce progressive pathologic rupture of the CCL. Therefore, these collagenolytic pathways may offer a novel target for medical therapy of joint inflammation in canine patients with cruciate disease.